CGEM - Cullinan Oncology GAAP EPS of -$0.54 beats by $0.43 November, 14 2022 09:17 AM Cullinan Oncology Inc. Cullinan Oncology press release ( NASDAQ: CGEM ): Q3 GAAP EPS of -$0.54 beats by $0.43 . Cash and investments of approximately $607 million as of September 30, 2022 For further details see: Cullinan Oncology GAAP EPS of -$0.54 beats by $0.43